Transcript segment

Baric Transcribed Interview (Redacted), pp.117-118 · baric_ti:utt:01014

Date: 2026-04-10 09:00 (day precision)
Type: transcript segment · interview
recipient: Ralph S. Baric, Harry Kazenoff, David T. Lambeth III, William Henderson, Clark Ervin, Jake Greenberg
speaker: Christina Salazar
Topics: Natural origin / zoonotic spillover

Did you have a UBMTA with NIH-RML? What's the date on this? It's from 2023, on pangolin beta coronaviruses, where it looks like you would be providing original material to Vincent Munster from RML. Pangolin coronavirus was the original material, and the transmittal fee to reimburse the provider for preparation and distribution costs amount is zero. Is that something that was executed? DC.Scheduling@LexitasLegal.com

Extracted statements

Rule-extracted, not adjudicated. The grade says what may be done with each one; read the document above before relying on any of them.

Statement	Grade	Attribution	Stance
It's from 2023, on pangolin beta coronaviruses, where it looks like you would be providing original material to Vincent Munster from RML.	quoted / not their view	hypothetical conditional framing	asserts
Pangolin coronavirus was the original material, and the transmittal fee to reimburse the provider for preparation and distribution costs amount is zero.	own voice, substantive	speaker_own	asserts

Statement

Grade

Attribution

Stance

It's from 2023, on pangolin beta coronaviruses, where it looks like you would be providing original material to Vincent Munster from RML.

quoted / not their view

hypothetical conditional framing

asserts

Pangolin coronavirus was the original material, and the transmittal fee to reimburse the provider for preparation and distribution costs amount is zero.

own voice, substantive

speaker_own

asserts

In context

A single line often inverts meaning once you see what it answers, so neighbouring messages are always shown.

2026-04-10 09:00 Christina Salazar open

-- are there cases where there may not be?
2026-04-10 09:00 Ralph S. Baric open

Well, sometimes for large program project grants there would be a universal MTA created among all of the researchers so that you can share reagents. That's one form. And the other form is somebody will call and ask you for reagents and you do an MTA agreement.
2026-04-10 09:00 Christina Salazar open

Going back to --
2026-04-10 09:00 Ralph S. Baric open

I would say that 99 percent of them were done as MTA agreements. There would probably be outliers, occasionally, but that would be on existing projects where collaborations exist through a grant, and reagents are needed to further the aims of the grant.
2026-04-10 09:00 Christina Salazar

Did you have a UBMTA with NIH-RML? What's the date on this? It's from 2023, on pangolin beta coronaviruses, where it looks like you would be providing original material to Vincent Munster from RML. Pangolin coronavirus was the original material, and the transmittal fee to reimburse the provider for preparation and distribution costs amount is zero. Is that something that was executed? DC.Scheduling@LexitasLegal.com
2026-04-10 09:00 Ralph S. Baric open

I recall sending them WIV1 and SHSC014 for studies in bats. It's possible that we sent them the pangolin coronavirus. I'd have to check the MTA agreements.
2026-04-10 09:00 Christina Salazar open

I guess, is that something that's published, the pangolin beta coronavirus? What is that?
2026-04-10 09:00 Ralph S. Baric open

I had mentioned it previously. It's called pangolin coronavirus GD strain, and it was published in Nature Microbiology.
2026-04-10 09:00 Christina Salazar open

And do you know what RML was doing with that?

Full conversation →